
Multimodal AI Platform for Modality Agnostic Drug Discovery™
We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery. 1910 is a Y Combinator company (Winter 2019). YC-listed status: Active.